Latest Blogs

May 24, 2018
In the midst of troubles in North Africa and Middle East, we keep up with oncology education and research and keep up hope for the betterment of patient care and advancement of science in Arab countries. 
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 24, 2018
As the NSABP celebrates its 60th anniversary in 2018, Dr. Harry D. Bear honors the organization's history and accomplishments.
May 23, 2018
IDEA and LIFe recipient Dr. Susmita Sharma is working hard during her U.S. fellowship so that she can achieve her dream of delivering exceptional cancer care to her patients in Nepal. 
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, FASCO, is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and an associate professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Feb 23, 2017
When the travel ban was announced, I worried for my patients and for my colleagues. I worried that medical care would be denied to international patients, including those who came to the U.S. for cancer care.
Feb 02, 2017
When it comes to many alternative therapies, the data is too sparse to inform discussions on benefits and/or risks, as my patient learned when her supplement use prevented her from continuing on a clinical trial.
Dec 27, 2016
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on visit after visit, and we get to know each of them too.
Dec 14, 2016
As we move forward in oncology, my hope is that we will see miraculous recoveries more often, guided not by chance but by a better understanding of cancer biology. The promise of precision medicine remains a real one that I firmly believe in.
Nov 21, 2016
Since the U.S. presidential election I have spoken with family and friends, many of whom who did not vote as I had, and you know what, they are still the same people they were before the election.
Nov 11, 2016
Not everyone shares my view of what constitutes a good death, and I’ve come to realize that when a patient has a very different view of the end of life from mine, it can be very difficult to do what’s right.

Pages